Blackstone and TPG Complete Acquisition of Hologic
Business Wire (Tue, 7-Apr 9:10 AM ET)
PRNewswire (Mon, 6-Apr 5:51 PM ET)
Hologic Announces CEO Retirement as Blackstone and TPG Go-Private Deal Nears Completion
Market Chameleon (Mon, 6-Apr 6:30 AM ET)
Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Go-Private Transaction
Business Wire (Mon, 6-Apr 8:00 AM ET)
1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates
Business Wire (Tue, 17-Mar 8:00 AM ET)
Business Wire (Wed, 4-Feb 8:15 AM ET)
Hologic Announces Financial Results for First Quarter of Fiscal 2026
Business Wire (Thu, 29-Jan 4:02 PM ET)
Globe Newswire (Sat, 17-Jan 1:00 PM ET)
Hologic Buyout: Blackstone and TPG Offer up to $79 Per Share—What This Means for Investors
Market Chameleon (Tue, 21-Oct 6:33 AM ET)
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Hologic trades on the NASDAQ stock market under the symbol HOLX.
As of April 15, 2026, HOLX stock price was flat at $76.01 with million shares trading.
HOLX has a beta of 0.04, meaning it tends to be less sensitive to market movements. HOLX has a correlation of 0.00 to the broad based SPY ETF.
HOLX has a market cap of $16.97 billion. This is considered a Large Cap stock.
Last quarter Hologic reported $1 billion in Revenue and $1.04 earnings per share. This fell short of revenue expectation by $-24 million and missed earnings estimates by -$.06.
In the last 3 years, HOLX traded as high as $87.88 and as low as $51.90.
The top ETF exchange traded funds that HOLX belongs to (by Net Assets): VTI, VOO, VB, VBR, VHT.
HOLX has underperformed the market in the last year with a price return of +29.2% while the SPY ETF gained +31.2%. HOLX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +1.1% and +0.6%, respectively, while the SPY returned +1.6% and +7.6%, respectively.
HOLX support price is $75.88 and resistance is $76.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HOLX shares will trade within this expected range on the day.
